Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced… EP News Bureau Nov 22, 2023 Neutropenia is characterised by persistently low levels of neutrophils due to the use of chemotherapy and other types of…
Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in US PTI Nov 24, 2022 The licensing pact has been inked between Evive and Acrotech Biopharma (Acrotech), a New Jersey-based and wholly-owned subsidiary…
